AUROPHARMA.NS

Aurobindo Pharma Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,497.80

+3.01%Jun 19, 2026

AI Brief

Market cap

$873.19B

52w range

—

P / E

—

EPS · FY 2026

$60.34

Volume

—

Revenue · FY 2026

$336.53B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Aurobindo Pharma Limited’s valuation

News pulse · 14d

3 storiesPositive +1.00All news →

06-22today

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1497.80

Change

+36.20%

Period high

$1546.70

Period low

$1022.20

Period start

$1099.702025-06-23

Through 2026-06-19

Fair value

Football field →

Weighted blend

$1,081.08

— vs spot

Recommendation

n/a

4 of 4 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

AUROPHARMA.NS

1,498+36.20%

H 1,550L 1,016MA50 1,438MA200 1,238Avg vol 1.4M

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Real Estate
+1.26%
Industrials
+1.00%
Basic Materials
+0.65%
Energy
+0.59%
Healthcare
+0.01%
Utilities
-0.07%
Financial Services
-0.24%
Communication Services
-0.55%
Technology
-0.80%
Consumer Cyclical
-0.85%
Consumer Defensive
-1.00%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
+0.88%
Biotechnology
+6.56%
Financial - Mortgages
-4.05%
Electrical Equipment & Parts
+3.88%
Staffing & Employment Services
-3.62%
Software - Services
-3.30%
Software - Infrastructure
-3.07%
Advertising Agencies
+2.92%
Apparel - Footwear & Accessories
-2.80%
Engineering & Construction
+2.80%
Financial - Conglomerates
+2.62%
Luxury Goods
+2.47%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Peers

No peer list available for AUROPHARMA.NS.

Total assets

$585.02B

Total debt

$80.73B

Cash & equiv

$98.7B

Operating CF

$55.13B

Free cash flow

$28.27B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$336.53B	$50.78B	$35.05B	$60.34	+10.41%